Jessica Hagen
Dr. Jing Wang, dean of Florida State University’s College of Nursing, joins MobiHealthNews to discuss "nursifying AI."
The company plans to offer an aggregate of 7.9 million shares of its common stock with an initial public offering price between $18 and $20 per share.
The company's computer vision technology tracks supply and implant usage in hospital operating and procedural rooms.
The company will use its platform to track and analyze Team USA athletes' health, training and nutrition data, and collect data on fans both at home and attending events.
Marcel Botha, cofounder and CEO of 10XBeta, warns that President Trump's tariffs may jeopardize the quality and safety of medical innovations and hinder patient care.
The WHA also approved the next phase of digital health strategy for 2028 to 2033.
The funds will be used to help the company expand into the employer and health plan markets and speed up the development of its AI technology for providers and members.
The company began trading on the NYSE today under the ticker symbol HNGE, opening at $39.25, up 23% from its IPO price of $32, and closing at $37.56 per share.
MedGemma, built on Gemma 3, aims to help developers build AI-based healthcare applications with open models, including multimodal and text-only versions.
The AI-powered COPD care coordination tool uses EHR data and natural language processing to identify and manage high-risk patients.